Synthesis of stereospecifically labelled [4-3H]cholesterol
β Scribed by W. J. S. Lockley; H. H. Rees; T. W. Goodwin
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- French
- Weight
- 352 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
β¦ Synopsis
HlCholesterol was prepared in three steps from 4-0xo-cholerrt-5-en-39-y1 acetate, which warn conveniently prepared f r o m cholesterol. Introduction of the h y H label utiliwd N d Y a8 the .wTce Of tritium. Iktail6 0 this 6ytIthe6i6 and a l m the amthesf8 of [+YH f cholesterol are given. ~ocedurctrn for quantitative estimation of the tritium label at the h and 48 positions are a l m described. Key word68 [h-' H'lcholesterol, [49-yH]cholesteml, 4-oxo-cholest-5-en-39-yl acetate. MTIMDUCTIW Metabolic modification of the A and B ring8 of steroids frequently involves mtereoupecific removal of a hydrogen from C-4 of cholesterol with formation of a A ' bond. metabolic transformations often necessitates the availability of both C ~Z -~H I and [k$-Hlcholesterol arbstratee. The preuent paper reports the synthesis of [h?Hlcholesterol; 8Ynthesis of 148-HI&ole&ero1 is only outlined briefly, since the reactions for the introduction of imtope at the 4p-position have been described previously Investigation of such I Y
π SIMILAR VOLUMES
The 4gnth-i~ o{ e n d a p d d e a t e (RK 4211 La- beUed w i t h t/tltiwn at ih p o L i n e iuhg u d ~a i b e d . ih, M e f f ' -~~o x p u c c m m u + l wten o t a N-cwtboxyaLh# & m i n e d d v a t i v e IUM aeac-Led w i t h L-[4,5-H J p o 4 i n e and M e urude neac- .tion mixtcute fneaked w i t h d
2-14C-oxazepam (z) d 4 C -(+)and -(-1 -7-chloro-l--methyl-5-phenyl-1,3,4,5-tetrahydro-3H-l,4-benzodiazepine-2--one (s and 2) as well as 2-14C-7-chloro-4-carbamoyl-l-methyl--5-phenyl-1,3,4,5-tetrahydro-3H-l,4-benzodiazepine-2-one (9-1 were synthesised from ~arbobenzoxy-glycine-1-~~C. The overall rad
## Abstract Indicine __N__βoxide, an antitumor agent possessing an unusual type of potential alkylating capacity, was recently selected for clinical trial. Radioactiveβlabelled indicine __N__βoxide was sought for studies of its biological properties relating to antitumor activity and toxicity. Avai